Controlling Heparin Induced Bleeding

Heparin is an anticoagulant medication used to prevent blood clots. However, its anticoagulant effect can sometimes lead to excessive bleeding, known as heparin-induced bleeding.

Protamine Sulphate: The Agent of Choice

The primary agent used to counteract the effects of heparin and control heparin-induced bleeding is Protamine sulphate. It acts as a specific heparin antagonist.

• Mechanism: Protamine sulphate is a positively charged molecule that binds to the negatively charged heparin molecule. This binding forms a stable complex, effectively inactivating heparin and restoring normal blood clotting.
• Administration: It is typically administered intravenously, and its effect is rapid.

Evaluating Other Options

The other options are not suitable for controlling heparin-induced bleeding:

• Injectable Vitamin K: Vitamin K is the antidote for warfarin (another anticoagulant), not heparin. It works by replenishing clotting factors depleted by warfarin.
• Whole blood: While it contains clotting factors, it's not a specific antidote for heparin and carries risks associated with blood transfusion. It might be considered in severe, life-threatening hemorrhage unresponsive to specific treatment, but it's not the primary 'agent of choice'.
• Fresh frozen plasma (FFP): Similar to whole blood, FFP contains clotting factors but is not a direct heparin antagonist. It is used for coagulopathy but isn't the specific reversal agent for heparin.

Therefore, Protamine sulphate is the correct choice for controlling heparin-induced bleeding.